|
|
 |
|
|
|
Topic Links |
Laboratory
Response to Biological Terrorism
PDF HTML |
New
Partnerships for Terrorism Preparedness
PDF HTML |
Select
Agent Program
PDF HTML |
Smallpox
Vaccination and Response
PDF HTML |
State and
Local Readiness
PDF HTML |
Strategic
National Stockpile
PDF HTML |
Terrorism
Preparedness and Emergency Response
PDF HTML |
|
|
CDC has been responding to public health emergencies for decades and has
been preparing for bioterrorism in particular since 1998. CDC's bioterrorism
plans were put into action in fall 2001, with the first biological attack in
the United States.
Outbreaks of anthrax proved that the first line of defense is rapid
identification—essential for ensuring a prompt response to a biological or
chemical attack so that exposure can be limited and those affected can be
treated. To accomplish this, regional and state laboratories have
strengthened their capacity to detect different biological and chemical
agents and to communicate the results to CDC and others. Along the same
lines, CDC's Health Alert Network has upgraded the capacity of state and
local health agencies to detect and communicate different health
threats—including bioterrorism, emerging infectious diseases, chronic
diseases, and environmental hazards. This means that we reap the benefits of
these investments every day, not just in the event of a bioterrorist attack.
Finally, to help treat victims of a bioterrorist attack, CDC has worked
with pharmaceutical companies and other partners to create regional
stockpiles of the drugs that would be needed quickly to treat man-made
outbreaks of anthrax, plague, tularemia, or other diseases. This resource
was essential in responding to the terrorist attacks of September 11, 2001,
as well as to the ensuing anthrax outbreak.
Collectively, these measures strengthen the existing public health system
while preparing for bioterrorism, infectious disease outbreaks, and other
public health threats and emergencies.
|
